Jeffrey Skene, PhD Health Canada

Jeffrey Skene has been with Health Canada since 2003. He began his career at Health Canada in Regulatory Affairs and later joined the group responsible for the review of monoclonal antibodies as a CMC reviewer. Today, Mr. Skene is the Acting Chief of the Monoclonal Antibodies Division that responsible for CMC review of mAb submissions, laboratory testing and On-Site Evaluations (OSE). He holds a M.Sc. in Biochemistry with a specialization in Molecular Biology.